![Biocon shares rise 2% on deal with Sandoz](https://images.assettype.com/fortuneindia%2F2023-05%2F3410245c-26e7-43b3-aae9-731b58e7e6ad%2FSourav_and_Devi_blog_pic.jpg?w=300&q=95)
Biocon shares rise 2% on deal with Sandoz
Biocon Biologics, a subsidiary of Biocon, has signed a distribution agreement with Sandoz for an immunity-linked injection in Japan.
Biocon Biologics, a subsidiary of Biocon, has signed a distribution agreement with Sandoz for an immunity-linked injection in Japan.
Biocon Ltd reported a decline in the net profit in the April to June quarter by 30% to ₹101.4 crore as against ₹144.40 crore in the same period last year.
Biocon declared a dividend of ₹1.50 per share for FY23, which includes payout on account of one-time exceptional gains arising from partial monetisation of its holdings in Syngene